The Beleford Lab studies underlying changes in molecular signaling that cause vascular malformations (abnormal development of blood vessels) in Hereditary Hemorrhagic Telangiectasia (HHT) and other genetic vascular conditions.

Our conditions of interest include: HHT, HHT-Juvenile Polyposis Syndrome, cutaneous capillary malformations, venous malformations, arteriovenous malformations (AVMs), lymphatic malformations, somatic overgrowth or hemihypertrophy, PIK3CA-Related Overgrowth Spectrum (PROS), and Myhre Syndrome.

If you have one of these conditions (or another genetic vascular condition), and are interested in participating in research, please contact our study coordinator Annika Gillam and our clinical research coordinator Alondra Gonzalez. They will inform you if we have any studies for which you'd be a good fit and can help enroll you.

Annika Gillam, MS, CGC is the study coordinator for the Beleford Lab. She is a board-certified genetic counselor with practical clinical experience in caring for patients with rare genetic conditions who was recruited to UC Davis in 2023.

Alondra Gonzalez, MPH, CRC is a clinical research coordinator with extensive experience in data collection and management, regulatory compliance, specimen handling, and direct patient care in clinical settings. She was recruited to the Beleford Lab in September 2025.

Daniah Beleford, MD, PhD, FACMG is the principal investigator for the Beleford Lab. She is a board-certified clinical geneticist with over eight years of experience as an attending physician for patients with rare genetic conditions.